Galenos Research is a clinical research center based in Dallas, Texas, dedicated to advancing clinical research while prioritizing patient safety and well-being. The center specializes in conducting Phase II to IV human clinical trials for the biopharmaceutical industry, leveraging over 16 years of experience in the field. Under the leadership of Dr. Rafael Canadas, a Board Certified physician and Certified Physicians Investigator, Galenos Research plays a crucial role in generating essential data for the Food and Drug Administration (FDA) to evaluate the safety and effectiveness of new medical products.

Currently, Galenos Research is actively recruiting participants for several clinical studies, including those focused on type 2 diabetes, osteoarthritis of the hip or knee, and diabetic kidney disease. Each study has specific eligibility criteria, such as age, medical history, and current medication use, and offers compensation for participation. The studies are designed to gather critical information through various assessments, including office visits, imaging tests, and daily diaries, contributing to the understanding and treatment of these conditions.

United States

Galenos Research is a comprehensive clinical research center in Dallas, TX, working in conjunction with the office of Rafael Canadas, M.D. to conduct Phase II-IV Clinical Trials.

Galenos Research

Company Details